摘要
BackgroundIt was recently demonstrated that a significant number of patients with common skin diseases across Europe are clinically depressed and anxious. Studies have shown that physicians not trained as psychiatrists underdiagnose depression. This has not been explored among dermatologists.
ObjectivesTo estimate the concordance between clinical assessment of depression and anxiety by a dermatologist and assessment with the Hospital Anxiety and Depression Scale (HADS).
MethodsThe study was an observational cross-sectional multicentre study of prevalent cases of skin diseases in 13 countries in Europe. Consecutive patients were recruited in outpatient clinics and filled in questionnaires prior to clinical examination by a dermatologist who reported any diagnosis of skin disease and signs of mood disorders.
ResultsAnalysis of the 3635 consultations showed that the agreement between dermatologist and HADS was poor to fair (lower than 0
ConclusionsDermatologists in Europe tend to underestimate mood disorders. The results suggest that further training for dermatologists to improve their skills in diagnosing depression and anxiety might be appropriate. When present, the psychological suffering of patients with dermatological conditions needs to be addressed.
What's already known about this topic?
It has recently been demonstrated that patients with common skin diseases have more depression and anxiety than controls. Research has shown that physicians who are not trained as psychiatrists miss depression in their patients.
What does this study add?
A large proportion of cases of depression in patients with skin disease are not diagnosed by dermatologists. These results indicate that further training for dermatologists to assess depression and anxiety might be appropriate.
Linked Editorial:Montgomery and Thompson. Br J Dermatol 2018; 179:237-238. Plain language summary available online Respond to this article
- 出版日期2018-8
- 单位河北医科大学